Sanofi SA vs VICI Properties Inc — how do they compare? Sanofi SA trades at $43.7 (market cap $104.30B), while VICI Properties Inc trades at $26 (market cap $28.61B). The key difference: Sanofi SA is far larger — about 3.6× VICI Properties Inc's market cap, and VICI Properties Inc pays the higher dividend (6.93%). Which is the better fit depends on your goals.
| SNY | VICI | |
|---|---|---|
Market Cap | $104.30B | $28.61B |
Sector | Health | Real Estate |
52-Week High | $52.34 | $33.78 |
52-Week Low | $41.33 | $25.94 |
Enterprise Value | $124.19B | $46.16B |
Dividend Yield | 5.55% | 6.93% |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →VICI Properties is an S&P 500 experiential real estate investment trust (REIT) that owns one of the largest portfolios of market-leading gaming, hospitality, and entertainment destinations, including Caesars Palace and MGM Grand. It utilizes a long-term, triple-net lease model to provide stable, inflation-protected income, serving as the primary landlord for the 'experience economy' while diversifying into non-gaming sectors like wellness, youth sports, and luxury resorts.
Read more on VICI →